Feeding Frenzy—Therapeutics Tap Tryptophan, Cathepsins, HDACs, Zinc
treatment group," he wrote in an e-mail to ARF (see full comment below).—Esther Landhuis None
379 RESULTS
You searched Esther
Sort By:
treatment group," he wrote in an e-mail to ARF (see full comment below).—Esther Landhuis None
systematic reviews and meta-analyses when evaluating the evidence on biomarkers.”—Esther Landhuis None
neurons with blocked lysosomal proteolysis.—Esther Landhuis None
Preliminary data from other labs suggest the mechanism operates in SCA7 and HD as well.—Esther Landhuis None
disorders. (see ARF related news story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2799
testing the therapeutic potential of anti-PrP antibodies, Rowan noted.—Esther Landhuis None
May 24.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2794 Alzheimer's Disease
hottest developments in this field with Esther Landhuis's unfolding coverage of the San Francisco
penetrate the topic of synaptic pathophysiology in neurodegenerative disease.—Esther Landhuis. This
tau,” Lovestone said.—Esther Landhuis. This is Part 3 of a four-part series. See also See also Part 1,
Souter and Lee, 2010).—Esther Landhuis. This is Part 2 of a four-part series. See also Part 1, Part 3,
developments, read Part 2.—Esther Landhuis. This is Part 1 of a four-part series. See also Part 2, Part 3, Part
effects, Tomita said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2778 Alzheimer's
November 2011 in San Diego.—Esther Landhuis. This concludes a three-part series. See also Part 1 and Part
FTD phenotype,” Boxer told ARF.—Esther Landhuis. This is Part 2 of a three-part series. See also Part